Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
31%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
OZEM
21
HOLDINGS
21%
ALSO IN PPH
PPH
26
HOLDINGS
17%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in OZEM |
Weight in PPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 16.0% | 18.8% | 16.0% | |
NOVO-NORDISK A/S-SPONS ADR | 17.6% | 7.5% | 7.5% | |
PFIZER INC | 4.2% | 4.8% | 4.2% | |
ASTRAZENECA PLC-SPONS ADR | 3.4% | 4.5% | 3.4% |
OZEM Overweight Relative to PPH
NOVO-NORDISK A/S-SPONS ADR | 10.0% | |
ROCHE HOLDING LTD | 4.9% | |
VIKING THERAPEUTICS, INC. | 4.8% | |
ZEALAND PHARMA A/S | 4.7% | |
INNOVENT BIOLOGICS, INC. | 4.0% | |
CHUGAI PHARMACEUTICAL CO LTD | 4.0% | |
AMGEN INC | 3.3% | |
TERNS PHARMACEUTICALS, INC. | 3.2% | |
HANMI PHARM CO LTD | 2.9% | |
REGENERON PHARMACEUTICALS | 2.6% |
OZEM Underweight Relative to PPH
JOHNSON & JOHNSON | -10.3% | |
NOVARTIS AG-ADR | -7.6% | |
MERCK & CO. INC. | -6.1% | |
ABBVIE INC | -4.6% | |
MCKESSON CORP | -4.6% | |
SANOFI-AVENTIS-ADR | -4.5% | |
BRISTOL-MYERS SQUIBB CO | -4.3% | |
ZOETIS INC | -4.3% | |
GLAXOSMITHKLINE PLC-SPON ADR | -4.2% | |
CENCORA INC | -3.8% |